Last Updated: June 24, 2026

Suppliers and packagers for DSUVIA


✉ Email this page to a colleague

« Back to Dashboard


DSUVIA

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Vertical Pharms DSUVIA sufentanil citrate TABLET;SUBLINGUAL 209128 NDA AcelRx Pharmaceuticals, Inc. 61621-430-01 1 TABLET in 1 POUCH (61621-430-01) 2018-11-02
Vertical Pharms DSUVIA sufentanil citrate TABLET;SUBLINGUAL 209128 NDA AcelRx Pharmaceuticals, Inc. 61621-430-11 10 TABLET in 1 CARTON (61621-430-11) 2018-11-02
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for DSUVIA

Last updated: May 31, 2026

DSUVIA suppliers: who manufactures, bottles, and distributes this pharmaceutical drug in the US and globally

Who are the DSUVIA suppliers and contract manufacturers?

No sufficient, sourceable information is available in the provided prompt to identify DSUVIA’s specific supplier roster (manufacturers, contract manufacturers, labeled distributors, or finished-dose packagers) with the level of detail required for patent, regulatory, and commercial decisions.

What is DSUVIA’s FDA status and which suppliers show up in the Orange Book or label?

No sufficient, sourceable information is available in the provided prompt to determine whether DSUVIA has an FDA reference listing or an Orange Book record and, if so, which companies are listed as applicants/manufacturers/distributors.

Which companies supply DSUVIA internationally (EU/UK/Canada) and how do routes differ?

No sufficient, sourceable information is available in the provided prompt to map DSUVIA’s international authorization holders, local MAHs, importers, or parallel distribution channels.

Are there multiple DSUVIA presentations (strengths, dosage forms, kits) with different suppliers?

No sufficient, sourceable information is available in the provided prompt to enumerate DSUVIA presentations and supplier-by-presentation assignments.

Do DSUVIA packaging and labeling suppliers differ from API manufacturers?

No sufficient, sourceable information is available in the provided prompt to identify upstream API sources versus downstream CMOs/packagers for DSUVIA.

What regulatory filings reveal DSUVIA manufacturing locations (NDA/ANDA/CMC)?

No sufficient, sourceable information is available in the provided prompt to extract DSUVIA manufacturing sites from FDA CMC sections, inspection databases, or application dossiers.

How does DSUVIA’s supply chain compare with other injectable analgesics in its class?

No sufficient, sourceable information is available in the provided prompt to perform a supplier landscape comparison against relevant comparator brands.


Key Takeaways

  • The prompt does not provide enough sourceable information to name DSUVIA suppliers (manufacturers, CMOs, packagers, distributors) or to tie them to FDA/Orange Book records or regulatory filings.

FAQs

  1. What companies are listed as manufacturers for DSUVIA on US drug labeling?
  2. Does DSUVIA have an Orange Book listing that identifies the applicant and strength-specific manufacturers?
  3. Which DSUVIA suppliers hold manufacturing authorizations for the US (sterile/injectable sites)?
  4. Are DSUVIA distributors different from the marketing authorization holders for export markets?
  5. What contract manufacturers are used for DSUVIA’s finished-dose kit components, labeling, and packaging?

References

(No references can be provided because no sourceable supplier/regulatory information is included in the prompt.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.